SARS-CoV-2对单克隆抗体和小分子药物的耐药性
1Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Cell chemical biology
|April 19, 2024
概括
在COVID-19大流行期间,抗病毒疗法迅速发展,但病毒耐药性正在出现. 本综述详细介绍了已知的耐药性突变,有助于开发下一代治疗方法.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于COVID-19的流行,需要快速开发抗病毒疗法.
- 治疗性单克隆抗体和小分子对控制疾病至关重要.
研究的目的:
- 综合审查现有的COVID-19抗病毒疗法的耐药性概况.
- 提供对这些病原体产生耐药性的病毒突变图谱.
- 为下一代抗病毒药物和流行病准备的发展提供信息.
主要方法:
- 科学出版物和临床数据的文献综述.
- 分析报告的与降低药物疗效相关的病毒突变.
- 对单克隆抗体和小分子抗病毒药物的耐药性数据的综合.
主要成果:
- 对于几乎所有开发的COVID-19抗病毒化合物,已经确定了耐药性.
- 特定的突变赋予对各种病原体的耐药性被目录.
- 新出现的抗药性模式凸显了病毒进化的动态性质.
结论:
- 了解抗病毒耐药性对于有效的COVID-19管理至关重要.
- 本综述作为一种资源,用于识别关键的抗性突变.
- 需要积极的战略来预测和应对未来的流行病中的病毒耐药性.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K


